Intellipharmaceutics International Inc.
OTC: IPCIF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Isa Odidi MBA,
- Employees
- 11
- Headquarters
- Toronto, Canada
- IPO year
- 2009
- Market cap
- $5.0M
- Website
- https://www.intellipharmaceutics.com
Loading IPCIF…
Loading profile data…Frequently asked questions about IPCIF
What does Intellipharmaceutics International Inc. (IPCIF) do?
Intellipharmaceutics International Inc. operates as a pharmaceutical firm primarily engaged in the research, development, and manufacturing of both novel and generic oral solid dosage medications that feature controlled and targeted release mechanisms. The company's U.S. operations are central to its work. Leveraging its unique and patented Hype...
Where does IPCIF trade?
Intellipharmaceutics International Inc. (IPCIF) trades on the Other OTC.
What sector is IPCIF in?
Intellipharmaceutics International Inc. (IPCIF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Intellipharmaceutics International Inc.?
Isa Odidi MBA, is the chief executive officer of Intellipharmaceutics International Inc. (IPCIF).
Where is Intellipharmaceutics International Inc. headquartered?
Intellipharmaceutics International Inc. is headquartered in Canada.
Does IPCIF pay a dividend?
Intellipharmaceutics International Inc. (IPCIF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IPCIF go public?
Intellipharmaceutics International Inc. (IPCIF) completed its initial public offering in 2009.